|
[1]YAN W,LIU X,MA H,et al.Tim-3 fosters HCC developmen by enhancing TGF-β-mediated alternative activation of macrophages[J].Gut,2015,64(10):1593-1604.
|
|
[2]DOWNEY CM,AGHAEI M,SCHWENDENER RA,et al.DMXAAcauses tumor site-specific vascular disruption in murine non-smal cell lung cancer,and like the endogenous non-canonical cyclic dinucleotide STING agonist,2'3'-cG AMP,induces M2 macrophage repolarization[J].PLoS One,2014,9(6):e99988.
|
|
[3]KONG LQ,ZHU XD,XU HX,et al.The clinical significance o the CD163+and CD68+macrophages in patients with hepatocellular carcinoma[J].PLoS One,2013,8(3):e59771.
|
|
[4]KAZANKOV K,RODE A,SIMONSEN K,et al.Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma[J].Scand J Clin Lab Invest,2016,76(1):64-73.
|
|
[5]EHLING J,TACKE F.Role of chemokine pathways in hepatobiliary cancer[J].Cancer Lett,2015.pii:S0304-3835(15)00411-5.
|
|
[6]SEKI E,DE MINICIS S,GWAK GY,et al.CCR1 and CCR5 promote hepatic fibrosis in mice[J].J Clin Invest,2009,119(7):1858-1870.
|
|
[7]BARASHI N,WEISS ID,WALD O,et al.Inflammation-induced hepatocellular carcinoma is dependent on CCR5 in mice[J].Hepatology,2013,58(3):1021-1030.
|
|
[8]WAN S,KUO N,KRYCZEK I,et al.Myeloid cells in hepatocellular carcinoma[J].Hepatology,2015,62(4):1304-1312.
|
|
[9]RODERFELD M,RATH T,LAMMERT F,et al.Innovative immunohistochemistry identifies MMP-9 expressing macrophages at the invasive front of murine HCC[J].World J Hepatol,2010,2(5):175-179.
|
|
[10]WU J,ZHANG J,SHEN B,et al.Long noncoding RNA lncT CF7,induced by IL-6/STAT3 transactivation,promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition[J].J Exp Clin Cancer Res,2015,34(1):116.
|
|
[11]QIAN BZ,POLLARD JW.Macrophage diversity enhances tumor progression and metastasis[J].Cell,2010,141(1):39-51.
|
|
[12]HE G,KARIN M.NF-κB and STAT3-key players in liver inflammation and cancer[J].Cell Res,2011,21(1):159-168.
|
|
[13]BUPATHI M,KASEB A,MERIC-BERNSTAM F,et al.Hepatocellular carcinoma:where there is unmet need[J].Mol Oncol,2015,9(8):1501-1509.
|
|
[14]LUO D,WANG Z,WU J,et al.The role of hypoxia inducible factor-1 in hepatocellular carcinoma[J].Biomed Res Int,2014,2014(3-4):409272.
|
|
[15]BURKE B,TANG N,CORKE KP,et al.Expression of HIF-1alpha by human macrophages:implications for the use of macrophages in hypoxia-regulated cancer gene therapy[J].J Pathol,2002,196(2):204-212.
|
|
[16]ZHU XD,ZHANG JB,ZHUANG PY,et al.High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma[J].J Clin Oncol,2008,26(16):2707-2716.
|
|
[17]CAPECE D,FISCHIETTI M,VERZELLA D,et al.The inflammatory microenvironment in hepatocellular carcinoma:a pivotal role for tumor-associated macrophages[J].Biomed Res Int,2013,2013(1):187204.
|
|
[18]MAO Y,WANG B,XU X,et al.Glycyrrhizic acid promotes M1macrophage polarization in murine bone marrow-derived macrophages associated with the activation of JNK and NF-κB[J].Mediators Inflamm,2015,2015:372931.
|
|
[19]TOSELLO-TRAMPONT AC,KRUEGER P,NARAYANAN S,et al.NKp46+natural killer cells attenuate metabolism-induced hepatic fibrosis by regulating macrophage activation in mice[J].Hepatology,2016,63(3):799-812.
|
|
[20]FAROOQUE A,AFRIN F,ADHIKARI JS,et al.Polarization of macrophages towards M1 phenotype by a combination of 2-deoxyd-glucose and radiation:implications for tumor therapy[J].Immunobiology,2016,221(2):269-281.
|
DownLoad: